Nanomedical Innovation: the SEON-concept for an Improved Cancer Therapy with Magnetic Nanoparticles
Author(s) -
Stefan Lyer,
Rainer Tietze,
Harald Unterweger,
Jan Zaloga,
Raminder Singh,
Jasmin Matuszak,
Marina Poettler,
Ralf P. Friedrich,
Stephan Duerr,
Iwona Cicha,
Christina Janko,
Christoph Alexiou
Publication year - 2015
Publication title -
nanomedicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.947
H-Index - 109
eISSN - 1748-6963
pISSN - 1743-5889
DOI - 10.2217/nnm.15.159
Subject(s) - nanomedicine , nanotechnology , nanotoxicology , magnetic nanoparticles , superparamagnetism , cancer therapy , nanoparticle , drug delivery , drug , iron oxide nanoparticles , cancer , materials science , medicine , medical physics , pharmacology , physics , magnetization , quantum mechanics , magnetic field
Nanomedicine offers tremendous opportunities for the development of novel therapeutic and diagnostic tools. During the last decades, extensive knowledge was gained about stabilizing and the coating of nanoparticles, their functionalization for drug binding and drug release and possible strategies for therapies and diagnostics of different diseases. Most recently, more and more emphasis has been placed on nanotoxicology and nanosafety aspects. The section of experimental oncology and nanomedicine developed a concept for translating this knowledge into clinical application of magnetic drug targeting for the treatment of cancer and other diseases using superparamagnetic iron oxide nanoparticles. This approach includes reproducible synthesis, detailed characterization, nanotoxicological testing, evaluation in ex vivo models, preclinical animal studies and production of superparamagnetic iron oxide nanoparticles according to good manufacturing practice regulations.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom